8-K: Avanos Medical Appoints Interim CFO Under Consulting Agreement

Avanos Medical has formalized a consulting agreement with Warren Machan, who will serve as Interim Chief Financial Officer, outlining his compensation and responsibilities.

Summary

• Avanos Medical, Inc. has entered into a consulting agreement with Warren Machan, who will serve as the company's Interim Chief Financial Officer.
• The agreement is effective from October 28, 2024, and will continue until May 31, 2025, unless terminated earlier by either party with 30 days' notice or due to Mr. Machan's death or disability.
• Mr. Machan will receive a monthly fee of $45,000 from October 28, 2024, to February 28, 2025, and $60,000 per month from March 1, 2025, to May 31, 2025.
• He is also eligible for two $45,000 cash bonuses, one after February 28, 2025, and another after May 31, 2025, contingent on the agreement remaining in effect and satisfactory performance.
• The agreement specifies that Mr. Machan is an independent contractor and not an employee of Avanos Medical, and he is responsible for his own taxes and benefits.
• Mr. Machan's duties include acting as the principal financial officer, assisting with the preparation of the 2024 annual report and subsequent quarterly reports, and developing the 2025 plan.

Sentiment

Score: 7

Explanation: The document is generally positive as it addresses a key leadership gap with a clear plan and compensation structure. However, the interim nature of the role and the associated costs temper the overall sentiment.

Positives

• The company has secured an experienced professional to fill the critical role of Interim CFO.
• The consulting agreement provides clear terms for compensation and responsibilities.
• The agreement includes performance-based bonuses, incentivizing Mr. Machan to perform his duties effectively.
• The agreement outlines a clear timeline for the interim role, providing stability during the transition period.

Negatives

• The agreement is for an interim role, indicating a lack of a permanent CFO at this time.
• The company will incur significant consulting fees and bonus payments for the interim CFO role.
• The agreement specifies that Mr. Machan is an independent contractor, which may limit the company's control over his work.

Risks

• The interim nature of the CFO role could create uncertainty and instability in the company's financial leadership.
• The company's reliance on an independent contractor for a key financial role may pose challenges in terms of integration and control.
• The performance-based bonuses are contingent on the subjective assessment of the CEO, which could lead to disputes.
• There is a risk that the interim CFO may not be fully aligned with the company's long-term strategic goals.

Future Outlook

The consulting agreement is set to end on May 31, 2025, unless terminated earlier, suggesting the company will need to find a permanent CFO by that time or extend the agreement.

Management Comments

• The company's Interim Chief Executive Officer will determine if Mr. Machan has performed his duties in a satisfactory manner.
• The company intends for the consulting engagement to be a full-time assignment.

Industry Context

The appointment of an interim CFO is not uncommon in the corporate world, especially during periods of transition or restructuring. This move suggests that Avanos Medical is addressing a leadership gap in its finance department, which is crucial for maintaining investor confidence and ensuring smooth operations.

Comparison to Industry Standards

• The use of consulting agreements for interim executive roles is a common practice, particularly in situations where a company needs to fill a position quickly or is undergoing a transition.
• The compensation structure, including a fixed monthly fee and performance-based bonuses, is typical for interim executive engagements.
• The terms of the agreement, such as the 30-day termination notice and the independent contractor status, are standard in consulting arrangements.
• Companies like Robert Half and Korn Ferry often provide interim executive staffing services, and the terms of this agreement are consistent with industry norms for such engagements.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of an interim CFO as a necessary step to ensure financial stability and reporting.
• Employees may experience some uncertainty due to the interim nature of the CFO role.
• Customers and suppliers are unlikely to be directly impacted by this change.

Next Steps

• Avanos Medical will need to either extend the consulting agreement or find a permanent CFO by May 31, 2025.
• Mr. Machan will be responsible for assisting with the preparation of the 2024 annual report and subsequent quarterly reports.
• Mr. Machan will take the lead in developing the company's 2025 plan.

Key Dates

Keywords

Interim CFO, Consulting Agreement, Financial Officer, Warren Machan, Avanos Medical, Compensation, Bonuses, Independent Contractor, Financial Reporting, Strategic Planning